PKPaul Komenda

Paul Komenda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul Komenda has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Navdeep Tangri

    Chronic Disease Innovation Centre, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada

    9 shared publications
  • Claudio Rigatto

    Department of Internal Medicine, University of Manitoba, Winnipeg, Canada

    6 shared publications
  • Claudio Rigatto

    Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Seven Oaks Hospital Chronic Disease Innovation Centre, Winnipeg, Manitoba, Canada

    5 shared publications
  • Manish M. Sood

    Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada

    5 shared publications
  • Navdeep Tangri

    Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Seven Oaks Hospital Chronic Disease Innovation Centre, Winnipeg, Manitoba, Canada

    3 shared publications
  • Barry Lavallee

    Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Diabetes Integration Project, Winnipeg, Manitoba, Canada

    2 shared publications

Latest Publications

  • Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective

    by Thomas W. Ferguson, Navdeep Tangri, Zhi Tan, Matthew T. James, Barry D.A. Lavallee, Caroline D. Chartrand, Lorraine L. McLeod, Allison B. Dart, Claudio Rigatto, Paul V.J. Komenda


  • The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program

    by Paul Komenda, Barry Lavallee, Thomas W. Ferguson, Navdeep Tangri, Caroline Chartrand, Lorraine McLeod, Audrey Gordon, Allison Dart, Claudio Rigatto


  • Risk Prediction in CKD: The Rational Alignment of Health Care Resources in CKD 4/5 Care

    by Peter Wojciechowski, Navdeep Tangri, Claudio Rigatto, Paul Komenda


  • Open Access

    Geographic and facility variation in initial use of non-tunneled catheters for incident maintenance hemodialysis patients

    by Edward G. Clark, Ayub Akbari, Brett Hiebert, Swapnil Hiremath, Paul Komenda, Charmaine E. Lok, Louise M. Moist, Michael E. Schachter, Navdeep Tangri, Manish M. Sood

    Non-tunneled (temporary) hemodialysis catheters (NTHCs) are the least-optimal initial vascular access for incident maintenance hemodialysis patients yet little is known about factors associated with NTHC use in this context. We sought to determine factors associated with NTHC use and examine regional and facility-level variation in NTHC use for incident maintenance hemodialysis patients. We analyzed registry data collected between January 2001 and December 2010 from 61 dialysis facilities within 12 geographic regions in Canada. Multi-level models and intra-class correlation coefficients were used to evaluate variation in NTHC use as initial hemodialysis access across facilities and geographic regions. Facility and patient characteristics associated with the lowest and highest quartiles of NTHC use were compared. During the study period, 21,052 patients initiated maintenance hemodialysis using a central venous catheter (CVC). This included 10,183 patients (48.3 %) in whom the initial CVC was a NTHC, as opposed to a tunneled CVC. Crude variation in NTHC use across facilities ranged from 3.7 to 99.4 % and across geographic regions from 32.4 to 85.1 %. In an adjusted multi-level logistic regression model, the proportion of total variation in NTHC use explained by facility-level and regional variation was 40.0 % and 34.1 %, respectively. Similar results were observed for the subgroup of patients who received greater than 12 months of pre-dialysis nephrology care. Patient-level factors associated with increased NTHC use were male gender, history of angina, pulmonary edema, COPD, hypertension, increasing distance from dialysis facility, higher serum phosphate, lower serum albumin and later calendar year. There is wide variation in NTHC use as initial vascular access for incident maintenance hemodialysis patients across facilities and geographic regions in Canada. Identifying modifiable factors that explain this variation could facilitate a reduction of NTHC use in favor of more optimal initial vascular access.


  • Improving the Quality and Efficiency of Conventional In‐center Hemodialysis

    by Jay Hingwala, Navdeep Tangri, Claudio Rigatto, Paul Komenda

    There is substantial variability at international, national, and regional levels in how effective dialysis providers are in the implementation of well-accepted interventions to deliver better health outcomes at reduced costs to payers. The growing number of dialysis patients within a finite pool of resources has led to searches for more efficient methods to provide patient care without compromising or diminishing quality. We review here some contemporary concepts surrounding quality improvement and operations research that may provide clinician administrators to both improve efficiency and quality in facility based hemodialysis units. The creation of balanced scorecards, utilization of process mapping techniques, and the application of LEAN principles may readily improve how hemodialysis care is delivered in an environment of increasing patient volumes and reduced operating resources.


  • The Cost Effectiveness of Erythropoietin-Stimulating Agents for Treating Anemia in Patients on Dialysis: A Systematic Review

    by Thomas Ferguson, Yang Xu, Ravindi Gunasekara, Blake Lerner, Kerry Macdonald, Claudio Rigatto, Navdeep Tangri, Paul Komenda

    Background: Anemia is a common complication associated with kidney failure and is marked by poor health and increased risk of morbidity and mortality. There are ongoing concerns with the use of Erythropoietin Stimulating Agents (ESAs) to treat anemia in patients with kidney failure on dialysis. Questions as to their benefits, harms and overall effect on quality of life are still relevant today. Our objective was to systematically review studies evaluating the cost-effectiveness of ESAs in patients with kidney failure on dialysis. Methods: We performed a systematic review of studies determining the cost-effectiveness of ESAs in adult patients on dialysis. Databases, including PubMed, EMBASE, and Cochrane Database of Systematic Reviews, were searched from their establishment until June 2013. Studies that reported an incremental cost-effectiveness ratio of hemoglobin correction strategies based on ESA treatments in comparison to red blood cell transfusions, lower hemoglobin targets, or no ESA treatment were included. Results: Seven studies met inclusion criteria. Reported cost/quality-adjusted life-year (QALY) ratios ranged from USD 931-677,749/QALY across five studies comparing ESAs to red blood cell transfusions. There was heterogeneity in results when considering higher hemoglobin targets, with studies finding higher targets to be both dominant and dominated. Mortality, hospitalization, and utility estimates were major drivers. Conclusions: There is substantial variability in the estimates of the cost-effectiveness of using ESAs in the dialysis population. New models incorporating recent meta-analyses for estimates of utility, mortality, and hospitalization changes would allow for a more comprehensive answer to this question.


  • Open Access

    Frailty and Physical Function in Chronic Kidney Disease: The CanFIT Study

    by Simon R. Walker, Ranveer Brar, Frederick Eng, Paul Komenda, Claudio Rigatto, Bhanu Prasad, Clara J. Bohm, Leroy J. Storsley, Navdeep Tangri

    Background: Frailty, a manifestation of unsuccessful aging, is highly prevalent in people with chronic kidney disease (CKD) and is associated with comorbid conditions in cross-sectional studies. Longitudinal studies investigating the progression of frailty in those with advanced non-dialysis CKD are lacking. Objectives: Canadian Frailty Observation and Interventions Trial (CanFIT). To determine the natural history, prevalence of perceived and measured frailty and its association with dialysis treatment choices and adverse outcomes in patients with advanced CKD. Design: Longitudinal observational study, designed to collect data from 600 participants over 2 years. Setting: Interprofessional non-dialysis CKD clinics at four tertiary health care centres in central Canada. Patients: People with CKD stage 4 and 5 (eGFR 2) who are not on dialysis at enrollment. Measurements: Multiple Frailty Definitions: Short Physical Performance Battery (SPPB), Fried Frailty Criteria, Frailty Index. Dialysis start: In-Centre Hemodialysis, Home Hemodialysis or Peritoneal Dialysis Outcomes: Death, Opt-out or Lost to follow up. Methods: We will perform physical and cognitive assessments annually. We plan to analyze the relationships between frailty, treatment choices and patient centered outcomes. Results: We have recruited 217 participants in 2 centres; of these, 56 % had reduced physical function at baseline, as defined by the SPPB. Risk of reduced physical function was 8 fold higher in those with diabetes after adjusting for age, gender, eGFR and comorbidities. Limitations: Referred population, use of SPPB as a measure of frailty, inter-operator variability in measurement of hand grip and gait speed, cross-sectional analysis of baseline data in the subset recruited to date. Conclusions: People with advanced CKD have a high burden of reduced physical function, especially those with diabetes. We will continue enrollment into the CanFIT study to further understand the clinical history of CKD and frailty in this population.


  • Open Access

    Mass Screening for Chronic Kidney Disease in Rural and Remote Canadian First Nations People: Methodology and Demographic Characteristics

    by Barry Lavallee, Caroline Chartrand, Lorraine McLeod, Claudio Rigatto, Navdeep Tangri, Allison Dart, Audrey Gordon, Stephanee Ophey, Paul Komenda

    Background: Screening the general population for Chronic Kidney Disease is not currently recommended. Rural and remote Canadian First Nations people suffer a disproportionate burden of Kidney Failure. The First Nat ions Community Based Screening to Improve Kidney Health and Prevent Dialysis ( FINISHED) project intends to test the hypothesis that a mobile, mass screening initiative available to all First Nations people 10 years of age and older residing in rural and/or remote communities, is feasible, will improve health outcomes and is cost effective. Objectives: The objective of this manuscript is to describe the key elements required to design, implement and evaluate such a program and describe key characteristics of our screened cohort. Design: Methods and cohort description. Setting: 11 First Nations communities within 2 Tribal Councils in Manitoba, Canada. Patients: All First Nations individuals between the ages of 10–80 living in the 11communities were eligible for the screening initiative. Measurements: Screening Rates achieved within communities. Methods: An interdisciplinary team partnership was established between the Diabetes Integration Project and the Manitoba Renal Program. Stakeholder consultation was obtained and protocols developed to mass screen community members using point of care testing equipment. All people screened were risk stratified, counselled and referred to nephrologists as required in real time, based on risk. Results: As of August 31, 2014, 1480 people in 11 communities over 2 Tribal Councils have been successfully screened. A mean screening rate of 21% of all community members eligible (aged 10–80) has been achieved. All patients at intermediate or high risk of kidney failure have been seen by nephrologists within 1 month of screening. Limitations: Long term outcomes of kidney failure rates not assessed for at least 5 years. Alternative public health initiatives to reduce kidney failure not investigated. Conclusions: Point of care mass screening, real time risk prediction and counselling of First Nations people at high risk of Kidney Failure is feasible in rural and remote communities. Further analysis of this cohort will describe theepidemiology of CKD in these communities, and test the cost effectiveness of this strategy.


  • Open Access

    Chronic kidney disease and support provided by home care services: a systematic review

    by Sema K Aydede, Paul Komenda, Ognjenka Djurdjev, Adeera Levin

    Chronic diseases, such as chronic kidney disease (CKD), are growing in incidence and prevalence, in part due to an aging population. Support provided through home care services may be useful in attaining a more efficient and higher quality care for CKD patients. A systematic review was performed to identify studies examining home care interventions among adult CKD patients incorporating all outcomes. Studies examining home care services as an alternative to acute, post-acute or hospice care and those for long-term maintenance in patients’ homes were included. Studies with only a home training intervention and those without an applied research component were excluded. Seventeen studies (10 cohort, 4 non-comparative, 2 cross-sectional, 1 randomized) examined the support provided by home care services in 15,058 CKD patients. Fourteen studies included peritoneal dialysis (PD), two incorporated hemodialysis (HD) and one included both PD and HD patients in their treatment groups. Sixteen studies focused on the dialysis phase of care in their study samples and one study included information from both the dialysis and pre-dialysis phases of care. Study settings included nine single hospital/dialysis centers and three regional/metropolitan areas and five were at the national level. Studies primarily focused on nurse assisted home care patients and mostly examined PD related clinical outcomes. In PD studies with comparators, peritonitis risks and technique survival rates were similar across home care assisted patients and comparators. The risk of mortality, however, was higher for home care assisted PD patients. While most studies adjusted for age and comorbidities, information about multidimensional prognostic indices that take into account physical, psychological, cognitive, functional and social factors among CKD patients was not easily available. Most studies focused on nurse assisted home care patients on dialysis. The majority were single site studies incorporating small patient populations. There are gaps in the literature regarding the utility of providing home care to CKD patients and the impact this has on healthcare resources.